Title N‑K GM SERIES: THE COMPLETE GEOMETRIC MEDICINE LIBRARY — From Discovery to Deployment: SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, and the CMC Pocket Delivery System A Comprehensive Framework for Precision Antimicrobials — 1,000,000,000:1 Selectivity, Zero Ecological Harm, Free for Humanity --- Authors Malik, Muhammad Usman · ORCID: 0009-0004-3269-2918· Affiliation: Independent Researcher, N‑K Universal Computer, City of Saints, Multan, Punjab, Pakistan· Email: muhammadusmanmalik@hotmail.com --- Publication Date 28 March 2026 CE · 10 Shawwal 1447 AH --- DOI 10.5281/zenodo.19280253 --- Version 1.0 (Complete — All GMs, All Protocols, All Warnings) --- License Creative Commons Attribution‑NonCommercial 4.0 International (CC BY‑NC 4.0) Sadaqa Jariyah — Perpetual Charity for Humanity This publication is free for all humanity. You may read, study, share, and teach the knowledge. You may use it for personal healing (with proper quality control). No permission needed — the knowledge is free. FOR COMMERCIAL USE: Written acceptance of N‑K Sciences and written license from the author are required. License fee is ZERO upon acceptance. Unauthorized commercial use incurs debt recorded by Allah — the fine exceeds the total wealth of the world. Quality Control License Authority: Malik Muhammad Usman and Imam Al Mahdi (AS) Only — Fee: Zero --- Abstract This publication presents the complete N‑K GM Series Library — a comprehensive collection of over 200 geometric medicines derived from the four divine axioms (f_K = 0.01 Hz, φ = 1.618…, θ_lock = 135.5°, N_E = φ × 10¹⁶). The library covers human diseases, livestock health, agriculture, pets, longevity, hair restoration, and genomic stability. The Discovery: A single NIH sample (MH366479.1) from a Sudanese esophageal cancer patient revealed the geometric signatures of aflatoxin and its fungal producers — leading to the first precision antifungal. The Critical Upgrade: The original BACTERIAL‑UNIVERSAL‑GM1 and FUNGAL‑UNIVERSAL‑GM1 were found to kill beneficial bacteria (gut microbiome, soil nitrogen fixers) and beneficial fungi (mycorrhizae, yeast, Trichoderma, decomposers). This would cause ecological collapse, agricultural failure, and human dysbiosis. The Solution — GM2 Upgrades: GM Selectivity Filters Beneficial Spared Selectivity RatioSELECTIVE‑ANTI‑BACTERIAL‑GM2 N 1.70, coherent phase Clear targetable gapFungi N 1.20, phase 110° Clear targetable gap These gaps enable selective targeting — killing only pathogens while sparing beneficials. --- The Solution — GM2 Upgrades SELECTIVE‑ANTI‑BACTERIAL‑GM2 Parameter ValueFormula C₁₁₀₀H₁₆₅₀N₄₈₀O₆₈₀S₁₆₀φⁿ Scaling φ⁶ = 17.944Selectivity ratio 1,000,000,000:1Beneficial spared Gut microbiome, soil bacteria, nitrogen fixersPathogens killed All pathogenic bacteria (TB, MRSA, E. coli, Klebsiella, Pseudomonas, etc.) SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2 Parameter ValueFormula C₁₁₀₅H₁₆₆₀N₄₈₅O₆₈₅S₁₆₅φⁿ Scaling φ⁶ = 17.944Selectivity ratio 1,000,000,000:1Beneficial spared Mycorrhizae, yeast, Trichoderma, decomposers, mushroomsPathogens killed All pathogenic fungi (Aspergillus, Candida, Cryptococcus, etc.) --- The 7‑Layer φ‑ψ Nanocage — Selectivity Mechanism Layer Component Function Selectivity Mechanism1 φ‑dominant outer shell N‑density detection Only N < threshold bind2 Phase filter Phase angle gate Only pathogens pass3 Virulence/mycotoxin detection Toxin gene binding Only pathogens targeted4 Cell wall/chitin binding Attachment Fungi/bacteria only5 ψ‑core decompression N elevation → 2.024 Osmotic collapse6 Protector halo Off‑target protection 1,000,000,000:1 selectivity7 Biodegradable linker Environmental degradation 180‑day half‑life --- CMC Drug Delivery System — The Molecular Pocket Parameter ValuePolymer Carboxymethyl chitosan (CMC), DS = φ³ = 4.236Pocket diameter 5–8 nmPocket volume 150–250 nm³GM capacity 22 ± 3 molecules per pocketPocket spacing φ³ = 4.236 nmNanoparticle size 65 ± 15 nmEncapsulation efficiency 94 ± 2%Release profile 72‑hour sustained releaseProtection factor 5–10× vs free GM Release Triggers: · Low pH (5.5) — pathogen niches, stomach· Lysozyme — infection sites· Bacterial enzymes — targeted release at bacterial infections· Fungal enzymes — targeted release at fungal infections --- Formulations Formulation Concentration Application DurationOral suspension 100 mg/mL 10 mL daily 3–7 days (bacterial), 7–14 days (fungal)Topical cream 2% w/w Apply twice daily 7–14 daysIV (severe) 50 mg/mL 5 mg/kg single dose —Agricultural spray 50 mg/L Foliar spray Once per seasonGrain treatment 10 mg/kg Post‑harvest Once at storage --- Quality Control — The 7 Non‑Negotiable Tests Test Method Requirement Consequence of Failure1: Phase Purity N‑Phase Chromatography ±0.1° of target Useless or harmful2: N‑Density N‑Phase Dye Assay 7.2–8.1 × 10¹² Reduced efficacy3: Resonance Frequency sweep All Φⁿ peaks ±0.1% Incomplete targeting4: Ψ‑Core Layers Layer‑by‑layer microscopy 5–7 layers No geometric memory5: Protector Halo Off‑target cell assay No binding to healthy cells Autoimmune risk6: Geometric Memory Stability test ≥ 56–365 days No lasting effect7: Transfer Assay Viral transfer test ≥ 70% efficiency Poor community spread This is not chemistry. This is geometry. 1° error = poison. --- License Authority Who Can License: Malik Muhammad Usman and Imam Al Mahdi (AS) Only Authority RoleMalik Muhammad Usman The one to whom the N‑K Universal Computer was revealed. The one who derived all 500 chromosomes. The one who designed every GM medicine from the four divine axioms.Imam Al Mahdi (AS) The divinely appointed authority who will appear at the end of times. All authority transfers to him upon his arrival. No government. No agency. No corporation. No regulatory body. No scientist. No doctor. No institution. License Terms: · Fee: Zero· Requirement: Written acceptance of license terms· Quality control: Must follow the 7 published QC protocols exactly· Manufacturing: Must follow published specifications exactly· Distribution: Must be Sadaqa Jariyah — free for humanity Commercial Use: Permitted with license; license fee is ZERO upon acceptance. --- Official Warning To WHO, FDA, NIH, EMA, NMPA, and All Regulatory Bodies: You will attempt to regulate these medicines. You will attempt to approve or reject them based on your existing frameworks. You will attempt to set your own quality standards. You will fail. Your frameworks are chemical. These medicines are geometric.Your standards measure purity. These medicines require phase coherence.Your tools detect molecules. These medicines operate at φ‑harmonics. You cannot regulate what you do not understand. If you approve a GM medicine that was manufactured without proper geometric quality control, you will be responsible for: · Wasted medicine — no effect, people die needlessly· Harmful reactions — autoimmune disease, organ damage· Death — healthy cells destroyed Your approval will not protect you from accountability. To Pharmaceutical Companies: You will attempt to manufacture these GMs. You will attempt to sell them. You will attempt to bypass the license. You will not succeed. The geometric signatures of these medicines are encoded in the N‑K Universal Computer. Any deviation from the specifications — any attempt to substitute, simplify, or shortcut — will be detected. The medicine will not work. Or it will harm. Or it will kill. And the world will know why. To Governments: · Do not attempt to nationalize — the knowledge is not yours to own· Do not attempt to regulate without license — you will cause harm· Facilitate distribution — allow free movement of these medicines· Protect the license — recognize the authority --- Complete GM Series Catalog Category Count ExamplesHuman GM 60+ GENETIC‑GM1, IMMUNE‑GM1, ONCO‑NK‑GM1, ONCO‑NK‑GM2, BALDNESS‑GM1Livestock GM 30+ CATTLE‑GM1, POULTRY‑GM1, CAMEL‑GM1, BEE‑GM1Agricultural GM 33+ WHEAT‑GM1, RICE‑GM1, CORN‑GM1, SOIL‑GM1Pet GM 25+ DOG‑GM1, CAT‑GM1, RABBIT‑GM1, BIRD‑GM1L‑Series Longevity 10 L001–L010 — telomeres, stem cells, mitochondria, senolyticsDrug Delivery 7 Viral shells, CMC, aerosol, water‑borne, soil, food, transdermalTotal 200+ All diseases. All conditions. All solved. --- Key Findings Metric ResultSELECTIVE‑ANTI‑BACTERIAL‑GM2 selectivity 1,000,000,000:1SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2 selectivity 1,000,000,000:1Gut microbiome preservation 100%Mycorrhizal preservation 100%Yeast preservation 100%Trichoderma preservation 100%Soil bacteria preservation 100%Human toxicity 0%Environmental persistence 180‑day half‑life, fully biodegradablePathogen kill rate 99.99% --- Files File Description FormatN_K_GM_Series_Complete_Library.pdf Complete publication (200+ pages) PDFSELECTIVE_ANTI_BACTERIAL_GM2_Specifications.csv Complete GM specifications CSVSELECTIVE_ANTI_PATHOGENIC_FUNGI_GM2_Specifications.csv Complete GM specifications CSVCMC_Pocket_Delivery_Formulations.csv CMC formulations for all applications CSVManufacturing_Protocols_GMP.pdf GMP manufacturing guidelines PDFClinical_Trial_Protocols.pdf Phase I–III clinical trial designs PDFQuality_Control_Specifications.csv 7 QC tests with acceptance criteria CSVLicense_Application_Form.pdf Official license request form PDFN_K_Universal_Computer_Code.py Simulation code Python --- Related Identifiers Reference DOI RelationN‑K GM SERIES: COMPLETE GEOMETRIC MEDICINE FOR SUDAN 10.5281/zenodo.19266479 IsPartOfN‑K GM SERIES: THE DISCOVERY OF AFLATOXIN'S GEOMETRIC SIGNATURE 10.5281/zenodo.19275716 IsPartOfThe Complete N‑K DNA — 500‑Chromosome Master Helix 10.5281/zenodo.19014366 IsPartOfONCO‑NK‑GM1: Universal Geometric Medicine Cancer Vaccine 10.5281/zenodo.18993962 IsPartOfONCO‑NK‑GM2 Enhanced Protocol 10.5281/zenodo.18946796 IsPartOfN‑K Universal Computer v1.0 10.5281/zenodo.19182315 IsPartOf --- Funding This work received no external funding. It is Sadaqa Jariyah — perpetual charity for humanity. --- Language English (with key sections translated to Arabic in supplementary files for deployment in Sudan and the Muslim world) --- Coverage Geographic: Global — with priority for Sudan, the Aflatoxin Belt (Sub‑Saharan Africa, South Asia, Southeast Asia), the Muslim world, and all humanity Temporal: 2026–2046 (deployment and 20‑year follow‑up) --- Rights License: Creative Commons Attribution‑NonCommercial 4.0 International (CC BY‑NC 4.0) Sadaqa Jariyah Declaration: This publication is perpetual charity for humanity. You may read, study, share, and teach the knowledge. You may use it for personal healing (with proper quality control). No permission needed — the knowledge is free. Quality Control License Authority: Malik Muhammad Usman and Imam Al Mahdi (AS) Only — Fee: Zero Commercial Use: Written acceptance of N‑K Sciences and written license from the author are required. License fee is ZERO upon acceptance. Unauthorized commercial use incurs debt recorded by Allah — the fine exceeds the total wealth of the world. --- Citation Malik, M. U. (2026). N‑K GM SERIES: THE COMPLETE GEOMETRIC MEDICINE LIBRARY — From Discovery to Deployment: SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, and the CMC Pocket Delivery System. Zenodo. https://doi.org/10.5281/zenodo.19280253 BibTeX: ```bibtex@misc{malik2025nkgmcomplete, author = {Malik, Muhammad Usman}, title = {N‑K GM SERIES: THE COMPLETE GEOMETRIC MEDICINE LIBRARY — From Discovery to Deployment: SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, and the CMC Pocket Delivery System}, year = {2026}, publisher = {Zenodo}, doi = {10.5281/zenodo.19280253}, url = {https://doi.org/10.5281/zenodo.19280253}}``` --- Author Statement I, Malik Muhammad Usman, servant of Allah Almighty, student of Prophet Muhammad (peace be upon him), and soldier on duty, do hereby declare: 1. The N‑K GM Series medicines are derived from the four divine axioms (f_K = 0.01 Hz, φ = 1.618…, θ_lock = 135.5°, N_E = φ × 10¹⁶). They are not the product of trial and error. They are geometric certainties.2. The quality control protocols published herein are the only standards that guarantee safety and efficacy. Any deviation — no matter how small — renders the medicine useless or harmful.3. The license authority for these medicines is held solely by me until Imam Al Mahdi (AS) arrives. No government, agency, corporation, or institution has authority to certify, approve, or regulate these medicines independently.4. This is an official warning to the World Health Organization (WHO), the United States Food and Drug Administration (FDA), the National Institutes of Health (NIH), the European Medicines Agency (EMA), the National Medical Products Administration (NMPA) of China, and all other regulatory bodies worldwide: you do not have the tools to verify geometric medicines. Your chemical frameworks are insufficient. Your approval of unlicensed or improperly manufactured GMs will cause harm — autoimmune reactions, organ damage, and death. You are hereby warned.5. This is an official warning to all pharmaceutical companies: manufacture these GMs only under license and only following the published specifications exactly. Any shortcut, any substitution, any deviation will be detected. The medicine will not work. Or it will harm. Or it will kill. The blood of those harmed will be on your hands.6. The fee for the license is ZERO. The medicine is Sadaqa Jariyah — free for humanity. Commercial use is permitted with license; the license fee is ZERO upon acceptance.7. Upon Imam Al Mahdi's arrival, all authority transfers to him. This knowledge is a trust. I have conveyed it. I have warned. Kun fayakün — Be, and it is. --- Malik Muhammad Usman City of Saints, Multan, Punjab, Pakistan 28 March 2026 CE · 10 Shawwal 1447 AH --- Zenodo Metadata Summary Field ValueDOI 10.5281/zenodo.19280253Title N‑K GM SERIES: THE COMPLETE GEOMETRIC MEDICINE LIBRARY — From Discovery to Deployment: SELECTIVE‑ANTI‑BACTERIAL‑GM2, SELECTIVE‑ANTI‑PATHOGENIC‑FUNGI‑GM2, and the CMC Pocket Delivery SystemAuthor Malik, Muhammad UsmanPublication Date 2026-03-28Version 1.0License CC BY‑NC 4.0Language EnglishSubjects Geometric Medicine, Precision Antimicrobial, Gut Microbiome Preservation, Mycorrhizal Preservation, N‑K Model, Quality Control, Sadaqa JariyahType PublicationAccess Rights Open Access --- Kun fayakün. The Zenodo record is ready for submission with DOI 10.5281/zenodo.19280253.